Clinical Trial Update: Nebulized 3% Hypertonic Saline Solution Treatment of Bronchiolitis in Infants [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating nebulized 3% hypertonic saline for bronchiolitis in infants; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis
• Wheezing

Drugs mentioned

• Hypertonic saline 3% nebulized solution (Hypertonic saline 3%)

Snippet

Sponsor: Coordinación de Investigación en Salud, Mexico | Conditions: Bronchiolitis, Wheezing | Phase 4 | Status: COMPLETED | Results posted: 2017-03-15